Phyllodes tumor of the breast: Local recurrence versus metastatic capacity

Human Pathology

Volumn 35, Issue 9, 2004, Pages 1051-1052

  Carter, Beverley A ^a   Page, David L ^b  

^a Health Care Corporation of St John's   (Canada)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CORRELATION ANALYSIS; CYSTOSARCOMA PHYLLOIDES; EDITORIAL; FIBROADENOMA; HISTOLOGY; HUMAN; MALIGNANT TRANSFORMATION; METASTASIS; PREDICTION; PROGNOSIS; TREATMENT PLANNING; TUMOR GROWTH;

BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PHYLLODES TUMOR; TUMOR MARKERS, BIOLOGICAL;

EID: 4444351700     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.08.001     Document Type: Editorial

References (14)

1. Moffat C.J., Pinder S.E., Dixon A.R., et al. Phyllodes tumours of the breast A clinicopathological review of thirty-two cases. Histopathology. 27:1995;205-218
2. Barth R.J. Jr. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat. 57:1999;291-295
3. Hajdu S.I., Espinosa M.H., Robbins G.F. Recurrent cystosarcoma phyllodes A clinicopathologic study of 32 cases. Cancer. 38:1976;1402-1406
4. Chaney A.W., Pollack A., McNeese M.D., et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer. 89:2000;1502-1511
5. Geisler D.P., Boyle M.J., Malnar K.F., et al. Phyllodes tumors of the breast A review of 32 cases. Am Surg. 66:2000;360-366
6. Zurrida S., Bartoli C., Galimberti V., et al. Which therapy for unexpected phyllode tumour of the breast? Eur J Cancer. 28:1992;654-657
7. Pietruszka M., Barnes L. Cystosarcoma phyllodes A clinicopathologic analysis of 42 cases. Cancer. 41:1978;1974-1983
8. Kok K.Y., Telesinghe P.U., Yapp S.K. Treatment and outcome of cystosarcoma phyllodes in Brunei A 13-year experience. J R Coll Surg Edinb. 46:2001;198-201
9. Norris H.J., Taylor H.B. Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases. Cancer. 20:1967;2090-2099
10. Kleer C.G., Giordano T.J., Braun T., et al. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol. 14:2001;185-190
11. Feakins R.M., Mulcahy H.E., Nickols C.D., et al. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome. Histopathology. 35:1999;162-169
12. Shpitz B., Bomstein Y., Sternberg A., et al. Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features. J Surg Oncol. 79:2002;86-92
13. Chen C.M., Chen C.J., Chang C.L., et al. CD34, CD117, and actin expression in phyllodes tumor of the breast. J Surg Res. 94:2000;84-91
14. Feakins R.M., Wells C.A., Young K.A., et al. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast. Hum Pathol. 31:2000;1214-1222